A modern building designed to meet the demands of today's innovative research
IRIC is part of a biomedical and pharmaceutical complex at the Université de Montréal. The exemplary donation of $12.5M from the Marcelle and Jean Coutu Foundation helped the Université build two new buildings on its campus dedicated to research and teaching in those two innovative fields. The buildings were named in recognition of this very important donation.
The Marcelle-Coutu Pavilion, a state-of-the-art building outfitted specifically to meet the demands of multidisciplinary research, is home to IRIC. Located on chemin de Polytechnique at the heart of the university campus, IRIC is linked to the Faculty of Pharmacy (Jean-Coutu Pavilion) via the Morris and Rosalind Goodman Agora.
This extraordinary donation by the Marcelle and Jean Coutu Foundation, the most generous given to a Francophone university at the time, is evidence of donors’ commitment to excellence in the fields of biomedical and pharmaceutical sciences in Quebec.
Height: 6 stories
Floor space: 19,343 m2
Capacity: 500 investigators, postdoctoral fellows, students, professionals, technicians and administrative staff
Research units: 28 (with a capacity for 7 more)
Research facilities: 10 (SPF Animal Facility, Bio-imaging, Bioinformatics, Biophysics, Flow Cytometry, Genomics, High-Throughput Screening, Histology, Medicinal Chemistry, Proteomics)
Project design & development: March 2002
Technical & functional program: July 2002
Beginning of excavation: January 2003
End of construction: December 2004
Project management: Tangram Experts-Conseils Inc.
Architectural consortium: Jodoin Lamarre Pratte et Associés – Nfoe et Associés – Birtz Bastien – Lemay et Associés
Structural engineering: Saia, Deslauriers, Kadanoff, Leconte, Brisebois, Blais
Mechanical/electrical engineering: Pellemon inc. – BPA Inc.
Construction management: Pomerleau inc.
The creation of IRIC is a testament to the commitment of Université de Montréal, the Government of Quebec and the Government of Canada to investigator-initiated basic research as the engine that drives improvement in public health.